Efficacy of liraglutide, a glucagon-like peptide-1 (GLP-1) analogue, on body weight, eating behavior, and glycemic control, in Japanese obese type 2 diabetes

BACKGROUND: We recently reported that short-term treatment with liraglutide (20.0 ± 6.4 days) reduced body weight and improved some scales of eating behavior in Japanese type 2 diabetes inpatients. However, it remained uncertain whether such liraglutide-induced improvement is maintained after discha...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Fujishima, Yuya, Maeda, Norikazu, Inoue, Kana, Kashine, Susumu, Nishizawa, Hitoshi, Hirata, Ayumu, Kozawa, Junji, Yasuda, Tetsuyuki, Okita, Kohei, Imagawa, Akihisa, Funahashi, Tohru, Shimomura, Iichiro
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2012
Teme:
Original Investigation
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3459720/
https://ncbi.nlm.nih.gov/pubmed/22973968
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1475-2840-11-107
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items